CNST expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.381800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.831800E-01
Normal-vs-Stage2
4.221000E-01
Normal-vs-Stage3
2.946600E-01
Normal-vs-Stage4
5.279600E-01
Stage1-vs-Stage2
6.092800E-01
Stage1-vs-Stage3
1.072990E-01
Stage1-vs-Stage4
7.547600E-01
Stage2-vs-Stage3
1.613240E-01
Stage2-vs-Stage4
4.576000E-01
Stage3-vs-Stage4
6.274400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.353000E-01
Normal-vs-AfricanAmerican
5.589600E-01
Normal-vs-Asian
3.967600E-01
Caucasian-vs-AfricanAmerican
4.634800E-01
Caucasian-vs-Asian
6.609200E-01
AfricanAmerican-vs-Asian
2.022600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.171600E-01
Normal-vs-Female
1.687350E-01
Male-vs-Female
3.670400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.615200E-01
Normal-vs-Age(41-60Yrs)
4.958800E-01
Normal-vs-Age(61-80Yrs)
9.224200E-02
Normal-vs-Age(81-100Yrs)
3.606200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.156800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.532400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.067800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.450040E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.359500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.214400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.833800E-01
Normal-vs-Daily Drinker
3.289800E-01
Normal-vs-Weekly Drinker
4.058000E-01
Normal-vs-Occasional Drinker
6.885000E-01
Normal-vs-Social Drinker
1.868990E-01
Non Drinker-vs-Daily Drinker
2.383800E-01
Non Drinker-vs-Weekly Drinker
7.998600E-01
Non Drinker-vs-Occasional Drinker
1.942600E-01
Non Drinker-vs-Social Drinker
1.823380E-01
Daily Drinker-vs-Weekly Drinker
2.603000E-01
Daily Drinker-vs-Occasional Drinker
1.023400E-01
Daily Drinker-vs-Social Drinker
6.222400E-02
Weekly Drinker-vs-Occasional Drinker
2.530200E-01
Weekly Drinker-vs-Social Drinker
4.275600E-01
Occasional Drinker-vs-Social Drinker
4.861000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.086000E-01
Normal-vs-Grade 2
5.929600E-02
Normal-vs-Grade 3
7.935800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.410800E-01
Grade 1-vs-Grade 3
3.973600E-01
Grade 1-vs-Grade 4
4.086000E-01
Grade 2-vs-Grade 3
4.566800E-01
Grade 2-vs-Grade 4
5.929600E-02
Grade 3-vs-Grade 4
7.935800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.080000E-01
Normal-vs-NonDiabetic
8.190500E-02
Diabetic-vs-NonDiabetic
6.891200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.849400E-01
Normal-vs-NoPancreatitis
7.926400E-02
Pancreatitis-vs-NoPancreatitis
5.934400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.907600E-01
Normal-vs-N1
4.177400E-01
N0-vs-N1
3.508800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.310200E-01
Normal-vs-TP53-NonMutant
4.122200E-01
TP53-Mutant-vs-TP53-NonMutant
2.082400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
